These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 9681155)

  • 1. Heparin and vasoactive peptides in hemodialysis patients.
    Hegbrant J; Ekman R; Thysell H
    Blood Purif; 1998; 16(3):135-9. PubMed ID: 9681155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of sham hemodialysis on plasma levels of vasoactive peptides in patients with uremia.
    Hegbrant J; Mårtensson L; Thysell H; Ekman R; Boberg U
    ASAIO J; 1992; 38(3):M197-200. PubMed ID: 1281014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of vasoactive regulatory peptides in patients receiving regular hemodialysis treatment.
    Hegbrant J; Thysell H; Ekman R
    Scand J Urol Nephrol; 1992; 26(2):169-76. PubMed ID: 1378231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dialysis fluid temperature and vasoactive substances during routine hemodialysis.
    Hegbrant J; Mãrtensson L; Ekman R; Nielsen AL; Thysell H
    ASAIO J; 1994; 40(3):M678-82. PubMed ID: 8555600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in plasma levels of vasoactive peptides during sequential bicarbonate hemodialysis.
    Hegbrant J; Thysell H; Mårtensson L; Ekman R; Boberg U
    Nephron; 1993; 63(3):309-13. PubMed ID: 8446269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in plasma levels of vasoactive peptides during standard bicarbonate hemodialysis.
    Hegbrant J; Thysell H; Mårtensson L; Ekman R; Boberg U
    Nephron; 1993; 63(3):303-8. PubMed ID: 8446268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of gastrointestinal regulatory peptides in patients receiving maintenance hemodialysis.
    Hegbrant J; Thysell H; Ekman R
    Scand J Gastroenterol; 1991 Jun; 26(6):599-604. PubMed ID: 1713707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octreotide inhibition of flushing and colonic motor dysfunction in carcinoid syndrome.
    Saslow SB; O'Brien MD; Camilleri M; von der Ohe M; Homburger HA; Klee GG; Pitot HC; Rubin J
    Am J Gastroenterol; 1997 Dec; 92(12):2250-6. PubMed ID: 9399764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of recombinant human erythropoietin on the plasma levels of vasoactive regulatory peptides in patients on maintenance hemodialysis.
    Hegbrant J; Thysell H; Ekman R
    Int J Artif Organs; 1991 Jul; 14(7):411-6. PubMed ID: 1889894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The circadian rhythm of atrial natriuretic peptide, vasoactive intestinal peptide, beta-endorphin and cortisol in healthy young and elderly subjects.
    Cugini P; Lucia P; Di Palma L; Re M; Canova R; Gasbarrone L; Cianetti A
    Clin Auton Res; 1992 Apr; 2(2):113-8. PubMed ID: 1386266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal peptide hormones during postoperative ileus. Effect of octreotide.
    Cullen JJ; Eagon JC; Kelly KA
    Dig Dis Sci; 1994 Jun; 39(6):1179-84. PubMed ID: 7515341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of vasoactive peptide release from brain to cerebral circulation during onset of migraine with aura.
    Friberg L; Olesen J; Olsen TS; Karle A; Ekman R; Fahrenkrug J
    Cephalalgia; 1994 Feb; 14(1):47-54. PubMed ID: 7515329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma neuropeptide Y concentrations in patients on hemodialysis.
    Akagi S; Nagake Y; Sugimoto T; Nakao K; Yamasaki H; Ichikawa H; Makino H
    Nephron; 2002 Oct; 92(2):333-8. PubMed ID: 12218311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of circuit and AV fistula clotting and detection of anti-PF4/heparin complex antibodies in hemodialysis patients suspected of having heparin-induced thrombocytopenia.
    Matsuo T; Wanaka K; Walenga JM
    Clin Appl Thromb Hemost; 2013; 19(1):73-8. PubMed ID: 22345486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Response of vasoactive substance to blood pressure changes during hemodialysis in uremic patients].
    Witkowicz J; Kokot F; Irzyniec T; Chudek J; Ficek R
    Pol Arch Med Wewn; 1999 Sep; 102(3):763-71. PubMed ID: 10949883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in plasma levels of vasoactive substances during routine acetate and bicarbonate hemodialysis.
    Hegbrant J; Mårtensson L; Thysell H; Ekman R; Boberg U
    Clin Nephrol; 1994 Feb; 41(2):106-12. PubMed ID: 8004826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between vasoactive substances and changes in blood pressure during hemodialysis].
    Takahashi M
    Nihon Jinzo Gakkai Shi; 1995 Oct; 37(10):549-57. PubMed ID: 7474507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Over-dialysis plasma RANTES increase depends on heparin dose and cardiovascular disease status.
    Naumnik B; Koc-Żórawska E; Myśliwiec M
    Adv Med Sci; 2013; 58(2):311-9. PubMed ID: 23959669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of erythromycin on gastric dysmotility and neuroendocrine peptides in rats with diabetes mellitus.
    Lin L; Ji M; Zhang HJ; Lin Z; Zhao ZQ
    Chin Med Sci J; 2005 Sep; 20(3):176-80. PubMed ID: 16261888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different effects of enoxaparin and unfractionated heparin on some thrombogenesis markers during hemodialysis: a cross-over study.
    Naumnik B; Pawlak K; Myśliwiec M
    Thromb Res; 2009 Feb; 123(4):631-6. PubMed ID: 18234290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.